Logo image
Does concomitant cholecystectomy at time of roux-en-y gastric bypass impact adverse operative outcomes?
Journal article   Peer reviewed

Does concomitant cholecystectomy at time of roux-en-y gastric bypass impact adverse operative outcomes?

Robert B. Dorman, Wei Zhong, Anasooya A. Abraham, Sayeed Ikramuddin, Waddah B. Al-Refaie, Daniel B. Leslie and Elizabeth B. Habermann
Obesity Surgery, Vol.23(11)
2013

Abstract

Adolescent Adult Aged Cholecystectomy Cholecystectomy, Laparoscopic Decision Support Systems, Clinical Female Gallbladder Diseases Gastric Bypass Humans Length of Stay Male Middle Aged Obesity, Morbid Patient Selection Postoperative Complications Prospective Studies Risk Assessment Risk Factors Time Factors Treatment Outcome United States Weight Loss creatinine acute kidney failure adult adverse outcome age distribution aged article blood transfusion cholecystectomy controlled study disease association female human intermethod comparison laparoscopic surgery length of stay major clinical study male outcome assessment patient assessment pneumonia postoperative complication postoperative hemorrhage postoperative period prediction priority journal risk assessment risk factor Roux Y anastomosis scoring system septic shock surgical infection surgical mortality surgical risk wound dehiscence
Background: We hypothesized that patients undergoing Roux-en-Y gastric bypass (RYGB) with concomitant cholecystectomy (RYGB + C) would be at greater risk for adverse events compared to patients undergoing RYGB alone. Methods: Patients who underwent a RYGB were identified in the 2005-2009 American College of Surgeons National Surgical Quality Improvement Program Database. Multivariate logistic regression with adjustment for confounding variables was utilized to identify risk factors for mortality at 30 days, major adverse events, and prolonged length of stay (PLOS). Results: We identified 32,946 patients who underwent RYGB; of these, 1,731 (5.2 %) underwent RYGB + C. Overall, RYGB + C was a risk factor for predicting major adverse events following laparoscopic but not open procedures. Regardless of approach, PLOS was more common among RYGB + C patients following adjustment. Overall mortality at 30 days was low and did not vary with concomitant cholecystectomy following adjustment. Conclusions: The risk for major adverse events is significantly greater for RYGB + C patients following laparoscopic procedures, and the risk for PLOS is greater for RYGB + C patients following both open and laparoscopic procedures. The short-term risks identified in this study can assist in decision-making when considering concomitant cholecystectomy at the time of RYGB. © 2013 Springer Science+Business Media New York.

Metrics

6 Record Views

Details

Logo image